752.62000 USD
11.33
1.53%
Last update Dec 15, 3:59 PM EST
Pre-market
Day range
746.38000
756.66998
Previous close
741.28998
Open
748.84998
Access this stock data via API
Subscribe
Regeneron Pharmaceuticals, Inc.
752.62
11.33
1.53%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 14.2B 13.1B 12.2B 16.1B
Cost of revenue 2.0B 1.8B 1.6B 2.4B
Gross profit 12.2B 11.3B 10.6B 13.6B
Operating expense
Research & development 5.2B 4.4B 3.6B 2.9B
Selling general and admin 3.0B 2.6B 2.1B 1.8B
Other operating expenses 53.4M -2.1M -89.9M -45.6M
Operating income 4.0B 4.2B 5.0B 9.0B
Non operating interest income
Income 711.4M 495.9M 160.1M 45.8M
Expense 55.2M 73M 59.4M 57.3M
Other income expense 133M -456.8M -235.9M 342.5M
Pretax income 4.8B 4.2B 4.9B 9.3B
Tax provision 367.3M 245.7M 520.4M 1.3B
Net income 4.4B 4.0B 4.3B 8.1B
Basic EPS 40.9 37.1 40.5 76.4
Diluted EPS 38.3 34.8 38.2 72.0
Basic average shares 107.9M 106.7M 107.1M 105.7M
Diluted average shares 107.9M 106.7M 107.1M 105.7M
EBITDA 5.2B 5.1B 5.5B 9.3B
Net income from continuing op. 4.4B 4.0B 4.3B 8.1B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 5 hours 14 minutes

04:15
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).